Related Experiment Video
Updated: Apr 22, 2026

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Protective effect of magnesium on indomethacin-induced gastric ulcer in mice
Roya Rostami1, Akram Eidi2, Pejman Mortazavi3
1Department of Biology, SR.C., Islamic Azad University, Tehran, Iran.
Abstract:
Gastric ulcer disease is a common problem of the gastrointestinal tract, with increasing incidence and prevalence attributed to a loss of balance between aggressive and protective factors. Gastric ulcer is a chronic condition characterized by damage to the mucosal, submucosal, and muscular layers of the stomach, primarily caused by excessive secretion of gastric acid, pepsin, and other digestive enzymes. The role of antioxidants in promoting ulcer healing is well established. Magnesium (Mg), being a main macro element, exhibits various beneficial effects, including antioxidant, analgesic, anti-inflammatory, antidiabetic, antacid, anti-apoptotic, and free radical-scavenging properties. In this study, we investigated the effect of magnesium sulfate (MgSO4) on indomethacin-induced gastric ulcers in male Balb/c mice. The effect of orally administered MgSO4 (0.05, 0.1, and 0.2 g/kg) was assessed in both gastric ulcer and healthy mice. The animals were randomly assigned to 10 groups: healthy control; sham; MgSO4 alone at 0.05, 0.1, or 0.2 g/kg; gastric ulcer control (indomethacin, 18 mg/kg); MgSO4 at 0.05, 0.1, or 0.2 g/kg) plus indomethacin; and omeprazole (20 mg/kg) plus indomethacin. Treatment were administered intragastrically for 14 consecutive days. All mice underwent a 24-h fasting period before the final day of treatment. Six hours after the last dose, indomethacin was administered orally to induce gastric ulceration. The mice were then sacrificed for histopathological and biochemical assessments. Administration of MgSO4 significantly reduced the ulcerated area, decreased malondialdehyde (MDA) levels, and increased gastric antioxidative enzyme activity, consistent with histopathological evidence of mucosal protection. In ulcer-induced mice, MgSO4 significantly decreased the expression of Epidermal Growth Factor (EGF), 70-kDa Heat Shock Protein (HSP-70), and Spasmolytic Polypeptide (SP) expression in the gastric tissue. In conclusion, magnesium may act as an anti-ulcerogenic and gastroprotective agent in mice.
More Related Videos
06:54Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists